Market

Agios Q2 2025 slides: PYRUKYND sales jump 45% as thalassemia approval nears

Agios Q2 2025 slides: PYRUKYND sales jump 45% as thalassemia approval nears
Read More

Related Posts

SpaceX may be worth more than half of Tesla — with a sixth of the revenue

SpaceX may be worth more than half of Tesla — with a si...

Alphabet CEO Pichai Sundar sells $10.3m in GOOGL stock

Alphabet CEO Pichai Sundar sells $10.3m in GOOGL stock

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $75,400

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares...

The Fed is running into a wall of its own making ahead of next week’s interest-rate vote

The Fed is running into a wall of its own making ahead ...

BioLife Solutions (BLFS) CFO Wichterman sells $771,600 in stock

BioLife Solutions (BLFS) CFO Wichterman sells $771,600 ...

Enanta Pharma CSO Or Yat Sun sells $34k in stock

Enanta Pharma CSO Or Yat Sun sells $34k in stock